OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell Carcinoma
Hong Wu, Xuefeng Leng, Qianshi Liu, et al.
Cancer Research (2023) Vol. 83, Iss. 18, pp. 3131-3144
Open Access | Times Cited: 46
Hong Wu, Xuefeng Leng, Qianshi Liu, et al.
Cancer Research (2023) Vol. 83, Iss. 18, pp. 3131-3144
Open Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Promising dawn in tumor microenvironment therapy: engineering oral bacteria
Zifei Wang, Wansu Sun, Ruixue Hua, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 60
Zifei Wang, Wansu Sun, Ruixue Hua, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 60
Broadening oncological boundaries: the intratumoral microbiota
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 17
Ying‐Qi Lu, Han Qiao, Xi-Rong Tan, et al.
Trends in Microbiology (2024) Vol. 32, Iss. 8, pp. 807-822
Open Access | Times Cited: 17
Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 23
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 23
Intratumoral microbiota: implications for cancer onset, progression, and therapy
Jinmei Wu, Pengfei Zhang, Wuxuan Mei, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 14
Jinmei Wu, Pengfei Zhang, Wuxuan Mei, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 14
Exploring the gut microbiota and its potential as a biomarker in gliomas
Dana Aljarrah, Naima Chalour, Amine Zorgani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116420-116420
Open Access | Times Cited: 10
Dana Aljarrah, Naima Chalour, Amine Zorgani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116420-116420
Open Access | Times Cited: 10
Causal relationship between gut microbiota and risk of esophageal cancer: evidence from Mendelian randomization study
Kui Wang, Jiawei Wang, Yuhua Chen, et al.
Aging (2024) Vol. 16, Iss. 4, pp. 3596-3611
Open Access | Times Cited: 7
Kui Wang, Jiawei Wang, Yuhua Chen, et al.
Aging (2024) Vol. 16, Iss. 4, pp. 3596-3611
Open Access | Times Cited: 7
Leveraging the intratumoral microbiota to treat human cancer: are engineered exosomes an effective strategy?
Jie Qiu, Yuancong Jiang, Nanwei Ye, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Jie Qiu, Yuancong Jiang, Nanwei Ye, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Microbes in the tumor microenvironment: New Additions to break the Tumor Immunotherapy Dilemma
Lujia Zhou, Shiying Fan, Wenjie Zhang, et al.
Microbiological Research (2024) Vol. 285, pp. 127777-127777
Closed Access | Times Cited: 5
Lujia Zhou, Shiying Fan, Wenjie Zhang, et al.
Microbiological Research (2024) Vol. 285, pp. 127777-127777
Closed Access | Times Cited: 5
Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes
Jiexi Yan, Lu Yang, Qingmiao Ren, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Jiexi Yan, Lu Yang, Qingmiao Ren, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
A machine learning radiomics based on enhanced computed tomography to predict neoadjuvant immunotherapy for resectable esophageal squamous cell carcinoma
Jialing Wang, Liansha Tang, Xia Zhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Jialing Wang, Liansha Tang, Xia Zhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics
Fei Peng, Mengyuan Hu, Zhiyue Su, et al.
Advanced Materials (2024) Vol. 36, Iss. 38
Closed Access | Times Cited: 4
Fei Peng, Mengyuan Hu, Zhiyue Su, et al.
Advanced Materials (2024) Vol. 36, Iss. 38
Closed Access | Times Cited: 4
Emerging roles of intratumor microbiota in cancer: tumorigenesis and management strategies
Zhuangzhuang Shi, Zhaoming Li, Mingzhi Zhang
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Zhuangzhuang Shi, Zhaoming Li, Mingzhi Zhang
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Unveiling the Intratumor Microbiome in Liver Cancer: Current Insights and Prospective Applications
Xindi Ke, Shangze Jiang, Qiaoxin Wei, et al.
Clinical and Molecular Hepatology (2025)
Open Access
Xindi Ke, Shangze Jiang, Qiaoxin Wei, et al.
Clinical and Molecular Hepatology (2025)
Open Access
Metabolic reprogramming and immunological changes in the microenvironment of esophageal cancer: future directions and prospects
Zhixun Guo, Jiali Ma, Jinqiu Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Zhixun Guo, Jiali Ma, Jinqiu Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A preoperative predictive model based on multi-modal features to predict pathological complete response after neoadjuvant chemoimmunotherapy in esophageal cancer patients
Yana Qi, Yanran Hu, Lin Cai, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yana Qi, Yanran Hu, Lin Cai, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Investigating the role of intratumoral Streptococcus mitis in gastric cancer progression: insights into tumor microenvironment
Ping Yang, Gaoli Liang, Yangyue Ni, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Ping Yang, Gaoli Liang, Yangyue Ni, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Recent progress on drug delivery systems of regulating intratumoral bacteria for tumor therapy
Jing Feng, Yanhong Liu, Liming Gong, et al.
Chinese Chemical Letters (2025), pp. 110907-110907
Closed Access
Jing Feng, Yanhong Liu, Liming Gong, et al.
Chinese Chemical Letters (2025), pp. 110907-110907
Closed Access
Association between preoperative inflammatory status via CALLY index and postoperative pneumonia occurrence in resectable esophageal squamous cell carcinoma patients: a retrospective cohort study
Minrui Fan, Yihan Zhu, Qian Long, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Minrui Fan, Yihan Zhu, Qian Long, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Intratumoral microbiome: implications for immune modulation and innovative therapeutic strategies in cancer
Na Wang, Si Wu, Lanxiang Huang, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Na Wang, Si Wu, Lanxiang Huang, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access
Review of metabolomics and microbiomics in esophageal cancer: From pathogenesis to prognosis
Yue Cao, Yan Cheng, Tiancheng Li, et al.
LabMed discovery. (2025), pp. 100045-100045
Open Access
Yue Cao, Yan Cheng, Tiancheng Li, et al.
LabMed discovery. (2025), pp. 100045-100045
Open Access
Oral microbes and gastrointestinal cancers: new strategies and insights
Chenlu Huang, Yu Li, Cong He
Clinical & Translational Oncology (2025)
Closed Access
Chenlu Huang, Yu Li, Cong He
Clinical & Translational Oncology (2025)
Closed Access
Zhi Zhao, Chunyi Peng, Yuanyuan Yang, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 7
Open Access
Factors of faecal microbiota transplantation applied to cancer management
Yi-Huang Liu, Juan Chen, Xiang Chen, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 2, pp. 101-114
Closed Access | Times Cited: 3
Yi-Huang Liu, Juan Chen, Xiang Chen, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 2, pp. 101-114
Closed Access | Times Cited: 3
Intratumoral Microbiome: Foe or Friend in Reshaping Tumor Microenvironment Landscape?
Athina A. Kyriazi, Makrina Karaglani, Sofia Agelaki, et al.
(2024)
Open Access | Times Cited: 3
Athina A. Kyriazi, Makrina Karaglani, Sofia Agelaki, et al.
(2024)
Open Access | Times Cited: 3
Intratumoral Bacteria as Mediators of Cancer Immunotherapy Response
Karen S. Sfanos
Cancer Research (2023) Vol. 83, Iss. 18, pp. 2985-2986
Closed Access | Times Cited: 7
Karen S. Sfanos
Cancer Research (2023) Vol. 83, Iss. 18, pp. 2985-2986
Closed Access | Times Cited: 7
